About Austrak
Austrak is a company based in Hyderabad (India) by Hemavani Guntuboina. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. The company has 140 employees as of March 31, 2023. Austrak offers products and services including Pharmaceuticals, Surgical Products, Ophthalmology Solutions, Nephrology Products, and Urology Products. Austrak operates in a competitive market with competitors including Cardinal Health, Syngene, Panacea Biotec, Kemwell Biopharma and Piramal Group, among others.
- Headquarter Hyderabad, India
- Employees 140 as on 31 Mar, 2023
- Founders Hemavani Guntuboina
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Austrak Pvt. Ltd.
- Date of Incorporation 21 May, 2016
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$1.14 M (USD)25.94as on Mar 31, 2023
-
Net Profit
$63.94 K (USD)33.38as on Mar 31, 2023
-
EBITDA
$95.51 K (USD)12.41as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
140
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Austrak
Austrak offers a comprehensive portfolio of products and services, including Pharmaceuticals, Surgical Products, Ophthalmology Solutions, Nephrology Products, and Urology Products.
Products are developed for preventing and treating diseases.
Surgical solutions are provided for various medical needs.
Innovative eye care technologies are offered for patients.
Kidney-related treatments are provided through specialized products.
High-standard medical products are delivered for urology care.
Funding Insights of Austrak
Detailed funding history for Austrak
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Austrak
Investment portfolio details for Austrak
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Austrak
Detailed financials for Austrak
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Austrak Comparisons
Peer comparison for Austrak
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Austrak
Austrak operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, Syngene, Panacea Biotec, Kemwell Biopharma and Piramal Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Multiple healthcare products and services are provided to organizations.
|
|
| Locked | Locked | Locked |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| Locked | Locked | Locked |
Developer of biosimilars, vaccines and natural products
|
|
| Locked | Locked | Locked |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| Locked | Locked | Locked |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| Locked | Locked | Locked |
Therapies for gastrointestinal disorders and related diseases are developed.
|
Detailed competitors of Austrak
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Austrak
Complete news archive for Austrak
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Austrak
Austrak is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Austrak is 140.
Annual revenue of Austrak is $1.14M as on Mar 31, 2023.
Austrak Pvt. Ltd. is involved in the development and supply of pharmaceuticals and surgical products. The company operates within the healthcare sector, focusing on specialties such as ophthalmology, nephrology, urology, cardiology, diabetology, gynaecology, neurology, and rheumatologyorthopedics. Products and services are designed to prevent, diagnose, and treat various diseases, aiming to improve peoples lives. Emphasis is placed on quality, innovation, and sustainable development, with a commitment to safety, health, and environmental protection across all facilities.
Austrak's top competitors include Syngene, Cardinal Health and Panacea Biotec.
Austrak offers Pharmaceuticals, Surgical Products, Ophthalmology Solutions, Nephrology Products, and Urology Products.